Odontoameloblastoma is an extremely rare tumor derived 
Introduction Odontoameloblastoma (OA) was defined by the World Health Organization (WHO) in 1971 as a rare neoplasm characterized by odontogenic epithelium and ectomesenchyme that may lead to dentin and enamel formation within the tumor. " 1 While fewer than 50 cases have been reported as OA, also known as ameloblastic odontoma, fewer than 20 fulfilled the WHO histologic classification. 2 Classic clinical presentation is described as asymptomatic involvement of the mandible or maxilla in young men with a median age at diagnosis of 20.2 years and a history of unerupted teeth. 3 The lesion is characterized by a slow, progressive growth pattern similar to that of other odontogenic tumors such as solid multicystic ameloblastoma. Imaging can be used to characterize extent of tumor involvement, and histology is required for diagnosis. Wide local excision and persistent surveillance are recommended given the locally destructive pattern of growth and risk of recurrence.
In this article we present what is, to the best of our knowledge, the first reported case of OA in an elderly woman and a brief review of the relevant literature. Although considered a disease of young people, OA should be included in the broader differential of lytic lesions involving the maxilla or mandible.
Case report
A 73-year-old woman was referred by an oral surgeon to our tertiary hospital for evaluation of a lytic lesion involving the mandible. She had originally presented to her dentist for a routine cleaning, during which x-rays were taken and an infection involving the mandible was diagnosed. When the infection failed to resolve, she was referred to an oral surgeon, who completed an excisional biopsy of two teeth and found pathology consistent with an odontogenic tumor.
The patient's medical history included chronic obstructive pulmonary disease, peripheral arterial disease, and an extensive cardiac history including aortic valve replacement and coronary artery bypass surgery.
At the time of presentation, the patient's physical examination, including a cranial nerve examination, was unremarkable. Computed tomography (CT) of her neck revealed a 2.7 × 3.5 × 2.5-cm destructive, loculated lesion involving the right anterior horizontal ramus of the mandible that extended across the midline and abutted the neural foramina. Gas density was observed within the lesion, and cortical bone thinning was present along the margins (figure 1).
Pathology from an excisional biopsy revealed abundant ameloblastic epithelium with stellate reticulum E44 www.entjournal.com
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Yalamanchi, coblens, ahn, cannadY, newman with scattered glands. In addition, there were frequent laminated calcifications and foci of dentin-like material, consistent with a diagnosis of OA.
The patient was informed about the benign, yet locally destructive, nature of the tumor and agreed to surgery. She was taken to the operating room for wide local excision including segmental mandibulectomy and scapular tip free tissue reconstruction (figure 2). This involved the mandible from left of the midline to approximately the right angle of the mandible, including the right inferior alveolar nerve. Neck exploration was completed for vessel identification, and harvest of a right scapular tip free flap was then performed. Given the patient's history of significant vascular disease, her fibula flaps were not usable. Reconstruction of the mandible with transosteal bone plate, microvascular anastomosis, and repair of the oral cavity defect was then performed.
Surgical histopathology revealed odontogenic epithelium with follicular and plexiform patterns adjacent to a variable amount of cellular myxoid tissue with mineralized dentin, consistent with the excisional biopsy ( figure 3 ).
The patient was discharged from the hospital on postoperative day 10 after an uneventful hospital course. She continues to have close follow-up, with visits every 6 months for a duration of 5 years, to monitor for recurrence.
Discussion
Odontoameloblastoma is a highly uncommon odontogenic tumor consisting of both ameloblasts, or odontogenic epithelium, and mesenchyme. In reported cases, OA affects young patients, with a mean age of 20.12 years; of those affected, approximately 60% are under the age 15.4 years. 1 While the tumor can occur in the posterior segment of the maxilla or mandible, it has been reported to have a predilection for the mandible. 1 Several theories have been proposed for the pathogenesis of OA. While one possibility is that proliferating epithelium over mesenchyme produces inductive stimuli that promote the growth of mineralized dental tissue such as a hamartoma, a less likely theory postulates separate development and collision of ameloblastoma and odontoma. 4 Several case reports have also reported this tumor in other species such as monkeys, sheep, and cats. 5 While OA typically presents asymptomatically, it is characterized as a progressively growing, centrally destructive lesion that leads to swelling of alveolar bone, malocclusion, and dull pain. 5 As with ameloblastoma, tumor growth can result in infiltration and destruction of surrounding bony tissues, leading to possible obstruction of the nasal and oral airways if left untreated. In addition, Yamamoto et al found expression of tenascin in the basement membrane of tumor epithelium and significant proliferating cell nuclear antigen staining, indicative of the high proliferation potential of the tumor. 6 On imaging, OA classically appears as a well-defined, radiolucent lesion that may contain radiopaque particles, indicative of dentin, or a larger radiopaque central mass, similar to that of a complex odontoma. The margins can be seen displacing surrounding teeth. 2 The differential diagnosis for radiolucent lesions with radiopaque material and similar clinical presentations includes compound or complex odontomas, calcifying epithelial odontogenic tumors, ameloblastic fibro-odontomas, and cemento-ossifying fibromas.
Histologic diagnosis is essential to differentiate OA from other odontogenic tumors that also contain ghost cells, such as calcifying odontogenic cysts and odontogenic ghost cell tumors. As in ameloblastoma, the odontogenic epithelial portion of the lesion has a plexiform or follicular pattern. The ameloblastic component is intertwined with dentin and enamel, as seen in some types of odontoma.
To make a diagnosis of OA, lesions must fulfill three histopathologic criteria, specifically the presence of (1) ameloblastoma; (2) homogeneous, mature connective tissue; and (3) fragments of calcified dental structures. 7 It is this combination of undifferentiated neoplastic tissue associated with highly differentiated tissue that contributes to the unusual pathology of OA.
Given its potential for bone expansion and local destruction, OA is treated similarly to ameloblastoma, with wide excision and close surveillance for several years. A recent review found a 21.4% rate of recurrence, meriting a minimum of 5 years of close follow-up. 8 A multidisciplinary team, including primary care dentists and oral and head and neck surgeons, is often required to optimize care.
Odontoameloblastoma is an exceedingly rare disease entity. The present case demonstrates the diagnosis and management of OA in an older demographic than previously described. Although considered a disease of young men, OA is an important diagnostic consideration in all patients presenting with lytic lesions involving the mandible or maxilla, as the tumor is locally destructive and surgical resection is curative. 
